Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.
about
Mortality among men and women in same-sex marriage: a national cohort study of 8333 DanesImpact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomesMetropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDSTrue story about HIV: theory of viral sequestration and reserve infectionDoravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations.Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts.Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya.Depressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: a prospective, observational study.Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cARTA comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.Migration patterns among Floridians with AIDS, 1993-2007: implications for HIV prevention and careSurvival analysis in infectious disease research: describing events in timePrevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and menAssociation of markers of hemostasis with death in HIV-infected women.Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007Liver disease in the HIV-infected individual.Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population levelSurvival of AIDS patients in Sao Paulo-Brazil in the pre- and post-HAART eras: a cohort studySurvival attributable to an exposure.Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang Powder.Prediction of the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approachMechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapyAn open-ended plea for the development of a global database of HIV vaccine responses.Poorer ART outcomes with increasing age at a large public sector HIV clinic in Johannesburg, South Africa.CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of DissentAntiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitorTrends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.Time to hospitalization for suicide attempt by the timing of parental suicide during offspring early development.Rural AIDS diagnoses in Florida: changing demographics and factors associated with survival.Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.
P2860
Q24657693-8FC54B45-D1D6-41FF-98EA-A52C9555BFB1Q26851997-24E10636-0892-4E49-84AE-A507CF663323Q28486380-DF4A9312-6BAB-4D19-94E1-A22E7EF8D664Q28732833-CB4EB62D-D34A-41C8-827B-62B29D6EBB51Q30373063-562AAB11-6267-4515-B4BC-0645780B15A5Q33386233-9F6CC83B-A6A2-4AB2-A6C3-59E3483F5D3AQ33388709-D46DDB91-C121-4F0E-BC45-845291276E81Q33567697-61188045-4D09-4955-9BD2-226E7513A8E2Q33585427-6B76A0EF-5ABD-4E5C-92F3-4693C80D1894Q33648774-7DF0BAFD-93E5-4BDD-A0DD-EAF3402A714BQ33686664-655DF1A9-E6C4-4586-8369-5C48AF8CE805Q33721818-01D98766-DDE3-4E25-BC3B-7D892BEAAB92Q33783987-19C6938B-3290-4DA3-94B1-1820263B58ECQ33883748-4D04CA21-3BFB-4843-A1BA-57F00D99B341Q34138241-8FA59C85-5F2F-45F2-85EC-94789454637AQ34195439-AD0037D5-B5E5-4C59-9268-4F8584933C83Q34295513-51CE4361-C719-40B8-8604-73E6641B1411Q34342193-C1FA927E-A4F9-4846-8BDC-97219F9212DBQ34348772-470BAC6A-2094-4168-850D-E771CD42F600Q34380326-FBF1DD44-8764-47D0-9BCE-66B8CE216D67Q34544751-7B7F9B1C-C8AA-487C-818F-1C4E0B67D5B9Q34588088-56DBE71A-9E78-49E0-8104-B67BB1E18BDDQ34673766-4BBEA05C-7BD2-4831-B979-364382576D85Q34854675-776B5A9D-77F4-4968-833D-E4D312BF600EQ34952453-4BCB4777-EFBB-4CF6-A6DD-744B68932DC8Q35012716-7FAEBD1E-C61D-4906-B6FF-010E3947B501Q35088160-ADA4FAAE-FA00-4B01-87BC-AC3140C692B5Q35275215-DDEF7497-5609-445A-8A1C-E1F07E7CFE93Q35659519-E5258370-6823-4CF4-BC56-70A4D3335E12Q35737660-85068900-F089-4817-8A46-3F95E5A24B47Q35800805-D6D95198-0830-4BEA-9B2E-A694CB29737CQ35834104-D5EF7780-14E3-4C2F-832C-3EA0313DE2D3Q35925705-329DCD6F-179E-4CF7-8300-B451DC590A1BQ36018893-347C6074-2C67-4DDE-86B6-1B5E5A31DF70Q36030846-093A02A0-3437-4228-ABEC-32C309CA0BB2Q36661756-A407DE72-3B66-459C-855A-393E331A5E97Q36876025-BEF11C0F-8584-45F8-A5C7-8EA6D234410FQ36962851-F7056349-476A-4996-9CAB-C944282713EBQ37117936-A21CAD1B-544E-4EDC-8778-D4B106A7D2FFQ37117942-E729FDFF-2648-4AE5-94F4-DB948A1F36D8
P2860
Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@ast
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@en
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@nl
type
label
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@ast
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@en
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@nl
prefLabel
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@ast
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@en
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@nl
P2093
P1433
P1476
Patterns of the hazard of deat ...... retroviral therapy: 1984-2004.
@en
P2093
Alvaro Muñoz
Carolyn M Williams
Kathryn Anastos
Lawrence Kingsley
Michael F Schneider
Roger Detels
Ruth M Greenblatt
Stephen J Gange
P304
P356
10.1097/01.AIDS.0000189864.90053.22
P407
P577
2005-11-01T00:00:00Z